Literature DB >> 25281996

[Nephrotic syndrome revealed by pulmonary embolism: about four cases].

E Chaudesaygues1, M Grasse1, L Marchand1, E Villar2, J-F Aupetit3.   

Abstract

Nephrotic syndrom is an association of proteinuria>3g/d or 50mg/kg/d, an hypoalbuminemia<30g/L and a hypoproteinemia<60g/L. Primary etiologies are minimal glomerular injury, focal segmental glomerulosclerosis and non membranous glomerulonephritis. Secondary etiologies are diabetes, high blood pressure and amyloidosis. We present four cases about nephrotic syndrome after thromboembolic disease. In every case, patients show a pulmonary embolism symptomatic of a nephrotic syndrom, whose diagnostic could be delayed up to six months after first pulmonary symptoms. This raised the problem of renal biopsy in these patients who need anticoagulation. In minimal change nephrosis, without hematuria, high blood pressure or renal dysfonction, a corticosteroid therapy test could be done assuming that is corticosensitive minimal glomerular injury. In every case, anticoagulation course must be completed and maintained in case of patent nephrotic syndrom with an albuminemia under 20g/L. In case of pulmonary embolism or deep vein thrombosis, idiopathic-looking, a nephrotic syndrome must be sought-after. The two diagnosis ways are the proteinuria on the urine dipstick and the hypoproteinemia on usual biology. The main mechanism is the coagulation factor leak, side effect of the nephrotic syndrom, notably because of the antithrombin III.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Deep vein thrombosis; Embolie pulmonaire; Maladie thrombo-embolique veineuse; Nephrotic syndrom; Proteinuria; Protéinurie; Pulmonary embolism; Syndrome néphrotique; Thromboembolic disease; Thrombose veineuse profonde

Mesh:

Substances:

Year:  2014        PMID: 25281996     DOI: 10.1016/j.ancard.2014.08.010

Source DB:  PubMed          Journal:  Ann Cardiol Angeiol (Paris)        ISSN: 0003-3928


  2 in total

1.  Splenic Infarction as Starting Symptom in Minimal Change Nephropathy.

Authors:  Qiu-Yue Li; Yu-Juan Yang; Qin-Kai Chen
Journal:  Chin Med J (Engl)       Date:  2017-03-05       Impact factor: 2.628

Review 2.  Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome.

Authors:  Donal J Sexton; Declan G de Freitas; Mark A Little; Tomas McHugh; Colm Magee; Peter J Conlon; Conall M O'Seaghdha
Journal:  Kidney Int Rep       Date:  2018-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.